Overview of Plasma Fractionation Market Size & Future Outlook

According to the latest report by MarkNtel Advisors, the Global Plasma Fractionation Market size is estimated to grow at a CAGR of around 7.1% from 2024-2030. This report is designed to enhance user understanding and support informed decision-making by thoroughly analyzing key market shifts, identifying gaps, exploring emerging opportunities, and assessing industry trends and competitive challenges. By combining both qualitative and quantitative data, it offers a comprehensive overview, highlighting growth prospects and providing valuable insights into competitors, helping both established companies and new entrants navigate the current market landscape.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure-  https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

What are the key drivers influencing the growth of the Plasma Fractionation market?

This section provides a detailed analysis of the market drivers and factors is explored thoroughly below.

Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies – Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, particularly immunoglobulins and coagulation factors during historical years.

Further, in response to this growing demand on a global scale, companies specializing in plasma fractionation have proactively started investing in expanding their plasma therapy manufacturing facilities. Such strategic initiatives by companies across the world position them to better address the increasing need for improved treatment, ultimately contributing to positive growth of the Plasma Fractionation Market.

How is the Plasma Fractionation market segmented and what are the key factors within each segment?

The Plasma Fractionation market has been further segmented into distinct categories. Analyzing growth within these segments allows you to identify niche opportunities, develop targeted strategies, and understand the variations in your core application areas and target markets.

By Product

  • Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
    • Intravenous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
    • Subcutaneous Immunoglobulin- Market Size & Forecast 2019-2030, (USD Million)
    • Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size & Forecast 2019-2030, (USD Million)
  • Coagulation Factors- Market Size & Forecast 2019-2030, (USD Million)
    • Factor VIII- Market Size & Forecast 2019-2030, (USD Million)
    • Factor IX- Market Size & Forecast 2019-2030, (USD Million)
    • Von Willebrand Factor (vWF) - Market Size & Forecast 2019-2030, (USD Million)
    • Prothrombin Complex Concentrates- Market Size & Forecast 2019-2030, (USD Million)
    • Fibrinogen Concentrates- Market Size & Forecast 2019-2030, (USD Million)
    • Factor XIII- Market Size & Forecast 2019-2030, (USD Million)
    • Others (Factor VIIa, Factor XI, etc.)- Market Size & Forecast 2019-2030, (USD Million)
  • Albumin- Market Size & Forecast 2019-2030, (USD Million)
  • Protease Inhibitor- Market Size & Forecast 2019-2030, (USD Million)
  • Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2019-2030, (USD Million)

By Application

  • Neurology- Market Size & Forecast 2019-2030, (USD Million)
  • Immunology- Market Size & Forecast 2019-2030, (USD Million)
  • Hematology- Market Size & Forecast 2019-2030, (USD Million)
  • Critical Care- Market Size & Forecast 2019-2030, (USD Million)
  • Pulmonology- Market Size & Forecast 2019-2030, (USD Million)
  • Rheumatology- Market Size & Forecast 2019-2030, (USD Million)
  • Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2019-2030, (USD Million)

By End User

  • Hospitals - Market Size & Forecast 2019-2030, (USD Million)
  • Specialty Clinics- Market Size & Forecast 2019-2030, (USD Million)
  • Research Facilities - Market Size & Forecast 2019-2030, (USD Million)

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific.

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

Who are the Key Market Players in the Plasma Fractionation industry?

The competitive landscape of the Plasma Fractionation market provides a detailed look at the key players in the industry. This includes an overview of each company, their financial performance, revenue generation, and market potential. It also covers their investments in R&D, new market initiatives, production facilities, and strengths and weaknesses. Additionally, the analysis looks at recent product launches, approvals, the range of products offered, their dominance in different applications, and the product life cycle. All of this information is specifically focused on how each company is positioning itself within the market.

Several key players are actively operating in the market, including

  • Biotest A.G.
  • Octapharma A.G.
  • Adma Biologics
  • Aegros
  • CSL Limited
  • Grifols S.A.
  • Kedrion Biopharma Inc.
  • Bio Products Laboratory Ltd                                  
  • Takeda Pharmaceuticals
  • Emergent Bio solutions
  • Intas Pharmaceutical
  • Plasma Gen Biosciences
  • S K Plasma
  • Australian Red Cross Lifeblood
  •  

Market Advancement by Leading Companies:

  • 2023: Bio Products Laboratory (BPL) announced the establishment of a strategic partnership with CSI Pharmacy to offer distribution rights to BPL’s immune globulin product Gammaplex.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

Other Report:

Why Choose MarkNtel Advisors:

  • Focused Industry Expertise
  • Diverse Report Offerings
  • Personalized Research Solutions
  • Robust Research Methodology
  • In-depth Report Coverage
  • Tracking Technological Advancements
  • Comprehensive Value-Chain Analysis
  • Discovering Market Opportunities
  • Analyzing Growth Trajectories
  • Assured Quality Insights
  • Dedicated After-Sales Support
  • Trusted by Fortune 500 Companies

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call + +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com